| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6020019 | Journal of Neuroimmunology | 2016 | 7 Pages |
Abstract
Antibodies against the MuSK Iglike-1 domain determine disease severity. Epitope spreading outside this domain did not contribute to disease severity nor to pyridostigmine responsiveness. This provides a rationale for epitope specific treatment strategies.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Maartje G. Huijbers, Anna-Fleur D. Vink, Erik H. Niks, Ruben H. Westhuis, Erik W. van Zwet, Robert H. de Meel, Ricardo Rojas-GarcÃa, Jordi DÃaz-Manera, Jan B. Kuks, Rinse Klooster, Kirsten Straasheijm, Amelia Evoli, Isabel Illa,